Chemotherapy trial proves the worth of including elderly patients in clinical trials

Doctors should be encouraged to include many more elderly people in clinical trials than they do at present, Dr Olavo Feher told the 3rd European Breast Cancer Conference in Barcelona today (Wednesday 20 March).

Dr. Feher, attending physician at the Hospital do Cancer in Sao Paulo, Brazil, said that the elderly were under-represented in clinical trials for cancer treatments, yet his research showed that useful results could be obtained if they were included in trials.

He said: Age is a known major risk factor for most cancers in adults. Approximately 50% of all new breast cancers occur in women aged 65 or older. However older women tend to be under-treated. Several clinical trials have shown that older women are less likely to receive post-operative radiation and systemic adjuvant therapy as compared to younger women. This population seems to be under-represented in clinical trials.

Dr. Feher told the conference that only women aged 60 or over were included in the randomized phase lll clinical trial that he and his colleagues co-ordinated in 18 countries world-wide*. The trial was performed to assess two chemotherapy agents (epirubicin and gemcitabine) as first-line, single agent treatments in elderly women with metastatic breast cancer. Both drugs are already known to be effective and well-tolerated in metastatic breast cancer, but it was not known how they would affect elderly women and what the correct doses should be. The median age of the women was 68 in the epirubicin arm of the trial and 69 in the gemcitabine arm of the trial.

Between October 1996 and February 1999, 397 women joined the trial. The results showed that both drugs were well tolerated, and that there were no differences in the womens quality of life between the two arms of the trial. Epirubicin proved to be more effective as the womens tumours responded better to it and their cancer did not start to progress again so quickly. The most common side effe

Contact: Emma Mason
Federation of European Cancer Societies

Page: 1 2

Related medicine news :

1. Chemotherapy, but not tamoxifen, associated with stroke risk after breast cancer treatment
2. Chemotherapy plus radiation therapy for head and neck cancer increases survival rates of some patients
3. Breakthrough New Therapy Uses Antibody-Targeted Chemotherapy To Fight Leukemia
4. Women Who Have Invasive Cervical Cancer Benefit From Addition Of Chemotherapy To Radiation Treatment
5. Discovery May Boost Effectiveness Of Chemotherapy
6. Promising New Drug Uses Antibody Targeted Chemotherapy To Fight Leukemia
7. BioNumerik Reports The Supercomputer Supported Discovery Of New, Non-Toxic Chemotherapy Protecting Agent
8. Better Survival For Women With Breast Cancer -New Evidence On Chemotherapy
9. Lack of clinical trial participation may contribute to lower survival rates
10. Protecting children from industrial chemicals in the environment
11. Hopkins begins human trials with donor adult stem cells to repair muscle damaged from heart attack

Post Your Comments:

(Date:2/14/2019)... N.H. (PRWEB) , ... February 14, 2019 , ... ... offers multi-year operating support which will directly impact Spaulding’s programs and services. , ... impact on our organization and in the lives of the children we serve ...
(Date:2/13/2019)... ... February 13, 2019 , ... Outside of nursing, most people ... also frequent hospital units, ambulatory care centers, clinics, and even emergency departments. Their ... second edition of What to Do When Nurses Hurt Nurses, published by Sigma ...
(Date:2/13/2019)... , ... February 13, 2019 , ... With Valentine’s Day ... transmitted disease (STD) testing service, is sharing 7 tips to ensure ‘Safe Sex’: ... if you’re going to engage in safe sex. Having clear, open, and honest communication ...
(Date:2/13/2019)... GREENWICH, Conn. (PRWEB) , ... February 13, 2019 , ... ... you must clear the white stuff from walkways and driveways. Then, the snow can ... about any joint or muscle you use to remove it,” says noted orthopaedic surgeon ...
(Date:2/13/2019)... PHOENIX (PRWEB) , ... February 13, 2019 , ... ... growing eye care practice management organizations in the nation, announced a new addition ... is the first-ever stand-alone oculofacial center created within a multi-specialty ophthalmology practice. ...
Breaking Medicine News(10 mins):
(Date:2/14/2019)... ... 14, 2019 , ... Strategic Radiology announces its newest independent ... Carolina. , “We are excited to welcome the physicians and support team ... Arl Van Moore Jr, MD, Strategic Radiology CEO and Chair. “When like-minded, high-quality ...
(Date:2/13/2019)... (PRWEB) , ... February 13, 2019 , ... Researchers from ... grant from the National Institute on Aging, part of the National Institutes of Health ... in aging biology. , The program’s goals are to establish follicle-stimulating hormone (FSH), ...
(Date:2/13/2019)... ... 13, 2019 , ... Sensible Surrogacy today has launched a ... childless couples who are unable to afford the staggering cost of surrogacy in ... North America or Eastern Europe for legal and secure surrogacy procedures. However North ...
Breaking Medicine Technology:
Cached News: